Role of complement C5a and histones in septic cardiomyopathy

Fatemeh Fattahi1, Lynn M Frydrych2, Guowu Bian2

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.

Molecular Immunology
|June 20, 2018
PubMed

Insights

Polymicrobial sepsis activates complement, releasing C5a. This triggers harmful events, including extracellular histones and NLRP3 inflammasome activation in heart cells, leading to septic cardiomyopathy.

Area of Science:

  • Immunology
  • Cardiology
  • Molecular Biology

Background:

  • Polymicrobial sepsis, induced by cecal ligation and puncture (CLP), leads to significant complement system activation and C5a release.
  • Sepsis-induced cardiomyopathy is a serious complication, characterized by impaired cardiac function and altered action potentials in cardiomyocytes (CMs).

Purpose of the Study:

  • To review the adverse events following complement activation in sepsis.
  • To elucidate the mechanisms linking C5a, extracellular histones, and cardiac dysfunction in sepsis.

Main Methods:

  • Review of existing literature on polymicrobial sepsis, complement activation, and cardiac dysfunction.
  • Analysis of the roles of C5a receptors (C5aR1, C5aR2), NLRP3 inflammasome, and extracellular histones in sepsis-related CMs events.

Main Results:

  • Sepsis robustly activates the complement system, releasing C5a, which binds to C5aR1 and C5aR2.
  • C5a and extracellular histones induce NLRP3 inflammasome activation, MAPK signaling, and defective action potentials in CMs.
  • Histone exposure reduces levels of key Ca2+ regulatory enzymes (SERCA2, NCX) and Na+/K+-ATPase in CMs, contributing to cardiac dysfunction.

Conclusions:

  • Complement component C5a and extracellular histones are key mediators of septic cardiomyopathy.
  • Targeting C5a receptors and mitigating histone-mediated damage may offer therapeutic strategies for sepsis-induced cardiac dysfunction.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.2K
Histone Modification02:32

Histone Modification

4.5K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
509
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
575